MY106776A - Solid dosage forms of almokalant and processes for manufacture thereof. - Google Patents

Solid dosage forms of almokalant and processes for manufacture thereof.

Info

Publication number
MY106776A
MY106776A MYPI91002267A MYPI19912267A MY106776A MY 106776 A MY106776 A MY 106776A MY PI91002267 A MYPI91002267 A MY PI91002267A MY PI19912267 A MYPI19912267 A MY PI19912267A MY 106776 A MY106776 A MY 106776A
Authority
MY
Malaysia
Prior art keywords
almokalant
manufacture
processes
dosage forms
solid dosage
Prior art date
Application number
MYPI91002267A
Inventor
Roger Simonsson Leif
Hjalmar Anderson Kjell
Elena Johansson Wingstrand Karin
Johan Gunnar Lundberg Per
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of MY106776A publication Critical patent/MY106776A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

SOLID ORAL PHARMACEUTICAL DOSAGE FORMS CONTAINING A COMPLEX OF ALMOKALANT AS WELL AS PROCESSES FOR THEIR MANUFACTURE.
MYPI91002267A 1990-12-07 1991-12-06 Solid dosage forms of almokalant and processes for manufacture thereof. MY106776A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (en) 1990-12-07 1990-12-07 SOLID DOSAGE FORMS OF A DRUG

Publications (1)

Publication Number Publication Date
MY106776A true MY106776A (en) 1995-07-31

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI91002267A MY106776A (en) 1990-12-07 1991-12-06 Solid dosage forms of almokalant and processes for manufacture thereof.

Country Status (26)

Country Link
EP (1) EP0560821A1 (en)
JP (1) JPH06503312A (en)
CN (1) CN1063039A (en)
AP (1) AP258A (en)
AU (1) AU8930791A (en)
BG (1) BG97851A (en)
CA (1) CA2097178A1 (en)
CZ (1) CZ103793A3 (en)
FI (1) FI932554A (en)
HU (1) HUT64217A (en)
IE (1) IE914137A1 (en)
IL (1) IL100150A0 (en)
IS (1) IS3788A7 (en)
LT (1) LTIP1717A (en)
MA (1) MA22355A1 (en)
MX (1) MX9102325A (en)
MY (1) MY106776A (en)
NZ (1) NZ240731A (en)
PT (1) PT99719A (en)
SE (1) SE9003902D0 (en)
SK (1) SK55693A3 (en)
TN (1) TNSN91117A1 (en)
TW (1) TW215057B (en)
WO (1) WO1992010172A1 (en)
YU (1) YU186891A (en)
ZA (1) ZA919264B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (en) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Solid instant release dosage forms and processes for their manufacture
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (en) * 1998-07-30 2010-07-14 佐藤製薬株式会社 Orally disintegrating tablets
JP7426685B2 (en) * 2018-06-14 2024-02-02 株式会社東洋新薬 tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE

Also Published As

Publication number Publication date
ZA919264B (en) 1992-08-26
IS3788A7 (en) 1992-06-08
CN1063039A (en) 1992-07-29
TW215057B (en) 1993-10-21
FI932554A0 (en) 1993-06-04
YU186891A (en) 1994-04-05
CA2097178A1 (en) 1992-06-08
PT99719A (en) 1992-10-30
IE914137A1 (en) 1992-06-17
IL100150A0 (en) 1992-08-18
AP258A (en) 1993-06-03
AU8930791A (en) 1992-07-08
BG97851A (en) 1994-04-29
TNSN91117A1 (en) 1992-10-25
NZ240731A (en) 1993-10-26
WO1992010172A1 (en) 1992-06-25
MX9102325A (en) 1992-06-01
JPH06503312A (en) 1994-04-14
FI932554A (en) 1993-06-08
EP0560821A1 (en) 1993-09-22
LTIP1717A (en) 1995-07-25
SE9003902D0 (en) 1990-12-07
HU9301670D0 (en) 1993-09-28
SK55693A3 (en) 1993-10-06
AP9100338A0 (en) 1992-01-31
HUT64217A (en) 1993-12-28
MA22355A1 (en) 1992-07-01
CZ103793A3 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
IL91768A0 (en) Compounds being therapeutics for aids,their production and pharmaceutical compositions containing them
DE3360065D1 (en) Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
ZA83362B (en) Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
GR890100583A (en) Method for the production of pharmaceutical compositions comprisig cyclosporins
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
IL99163A0 (en) Inhibitors for serine proteases,their preparation and pharmaceutical compositions containing them
NZ232084A (en) Amino-phenyl-n-heterocyclic (ring b) compounds and pharmaceutical compositions
IL85972A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
ZA905861B (en) Pharmaceutical composition for oral administration containing nac
IL89752A0 (en) Bisphosphonates,their production and pharmaceutical compositions containing them
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
IL87374A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
MY106776A (en) Solid dosage forms of almokalant and processes for manufacture thereof.
IL85970A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL84728A (en) Bicyclic v-triazine-4-one derivatives,their manufacture and pharmaceutical compositions containing them
IL86640A (en) Methoxymethyl penem compounds, their preparation and pharmaceutical compositions containing them
IL91246A0 (en) Benzodiazepine compounds,their production and pharmaceutical compositions containing them
NO180450C (en) Pharmaceutical formulations and process for the preparation of Form II dirithromycin
AU2798689A (en) Oral dosage units for pharmaceuticals and their use and preparation
IL85624A0 (en) Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
JO1718B1 (en) Solid dosage forms of almokalant and processes for manufacture thereof
IL90958A0 (en) Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them